Pharmaceuticals & Medical Devices

Pharmaceuticals & Medical Devices

Pharmaceuticals and health care devices and supplies are strictly regulated. Gain the benefit of best practices honed by our long-term and versatile experience of the field.

Our services include: 

  • Pricing and reimbursability
  • Marketing regulations and codes of ethics
  • Contractual matters
  • Pharmaceutical importing and permitting matters, authority matters
  • Matters related to pharmaceutical patents (including patent disputes)
  • Health care devices and supplies, health technology

Our clients include international and domestic pharmaceutical companies and manufacturers, distributors and developers of heath care devices and supplies.

Latest references

We advised Swedbank AB (publ) on the refinancing of a large Finnish retail real estate portfolio owned by Trophi’s Finnish subsidiaries. Trophi is the leading Nordic real estate company focusing on grocery anchored retail properties, with 278 properties across Sweden and Finland. Finland is a market that continues to develop and is also strategically important for Trophi, accounting for approximately 30% of Trophi’s letting and property value.
Case published 17.7.2026
We are acting as Finnish legal advisor to HANZA in connection with its acquisition of Fortaco Finland’s heavy mechanics and assembly business. The transaction is structured as a combined asset and share acquisition and includes Fortaco Finland’s heavy mechanics and assembly operations in Finland, as well as shares in two Estonian and two Polish subsidiaries. The transaction is expected to close during the fourth quarter of 2026, subject to customary closing conditions, including regulatory approvals. Founded in 2008, HANZA is a Swedish mechanical engineering and electronics contract manufacturing company listed on the Nasdaq Stockholm main list. HANZA has approximately 5,000 employees and annual sales of SEK 10 billion. We advise HANZA on this transaction in collaboration with the Swedish law firm Lindahl.
Case published 15.7.2026
We acted as Finnish counsel to RVRC Holding AB (RevolutionRace) in its acquisition of 90.1% of the shares in ICANIWILL AB (ICIW). Mannheimer Swartling (Sweden) acted as lead counsel for RevolutionRace. ICIW, founded in Sweden in 2012, is a Swedish training apparel brand.  RevolutionRace is a fast-growing Swedish outdoor brand offering multifunctional products to people with an active lifestyle. The company operates with a digital D2C business model reaching customers in approximately 40 countries. The company is listed on Nasdaq Stockholm since 2021. 
Case published 14.7.2026
We advised a special investment fund managed by Mandatum on the sale of the PMK Building, a mixed-use commercial property located in Tammela, Tampere. The property hosts dozens of tenants and offers, inter alia, warehouse, production and office premises.
Case published 13.7.2026